BB&T Corp cut its stake in shares of Anthem Inc (NYSE:ANTM) by 2.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,419 shares of the company’s stock after selling 2,921 shares during the quarter. BB&T Corp’s holdings in Anthem were worth $25,323,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently modified their holdings of the stock. WINTON GROUP Ltd raised its position in shares of Anthem by 138.2% in the 3rd quarter. WINTON GROUP Ltd now owns 80,291 shares of the company’s stock worth $22,004,000 after acquiring an additional 46,590 shares in the last quarter. Monument Capital Management bought a new position in shares of Anthem in the 4th quarter worth approximately $1,886,000. Visionary Asset Management Inc. bought a new position in shares of Anthem in the 3rd quarter worth approximately $223,000. Diligent Investors LLC bought a new position in shares of Anthem in the 3rd quarter worth approximately $200,000. Finally, Advisors Asset Management Inc. raised its position in shares of Anthem by 48.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 15,646 shares of the company’s stock worth $2,353,000 after acquiring an additional 5,086 shares in the last quarter. Institutional investors own 97.06% of the company’s stock.
ANTM stock opened at $305.70 on Thursday. Anthem Inc has a twelve month low of $215.52 and a twelve month high of $311.60. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.56 and a quick ratio of 1.54. The company has a market cap of $78.69 billion, a P/E ratio of 19.24, a P/E/G ratio of 1.15 and a beta of 0.95.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Monday, March 18th will be given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 1.05%. The ex-dividend date of this dividend is Friday, March 15th. This is a positive change from Anthem’s previous quarterly dividend of $0.75. Anthem’s dividend payout ratio (DPR) is 18.88%.
In other Anthem news, EVP Peter D. Haytaian sold 3,000 shares of the stock in a transaction on Thursday, December 27th. The stock was sold at an average price of $256.31, for a total transaction of $768,930.00. Following the sale, the executive vice president now directly owns 42,206 shares in the company, valued at approximately $10,817,819.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Gloria M. Mccarthy sold 7,700 shares of the stock in a transaction on Friday, January 18th. The shares were sold at an average price of $265.00, for a total value of $2,040,500.00. Following the sale, the executive vice president now owns 46,456 shares in the company, valued at $12,310,840. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,400 shares of company stock valued at $6,545,411. 0.31% of the stock is owned by corporate insiders.
ANTM has been the subject of several research reports. Argus initiated coverage on Anthem in a research report on Thursday, January 24th. They issued a “buy” rating and a $333.00 target price for the company. Morgan Stanley increased their target price on Anthem from $368.00 to $372.00 and gave the stock an “overweight” rating in a research report on Thursday, November 1st. Stephens increased their target price on Anthem from $310.00 to $350.00 and gave the stock an “overweight” rating in a research report on Thursday, January 31st. Cantor Fitzgerald reissued a “buy” rating and issued a $275.00 target price on shares of Anthem in a research report on Thursday, October 25th. Finally, Barclays reissued a “buy” rating and issued a $282.00 target price on shares of Anthem in a research report on Sunday, January 6th. Two analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Anthem presently has a consensus rating of “Buy” and an average price target of $329.93.
TRADEMARK VIOLATION WARNING: This story was reported by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/02/14/bbt-corp-cuts-stake-in-anthem-inc-antm.html.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.